Target intelligence / Profile preview

ADAM metallopeptidase domain 3B (ADAM3B)

Target
ADAM3B
Molecular classification
Other (membrane-anchored ADAM family protein), Pseudogene (in humans), Enzyme family (ADAM family)
01

Overview

ADAM metallopeptidase domain 3B, commonly known as cyritestin 2 (ADAM3B), is a member of the ADAM (a disintegrin and metalloproteinase) gene family that encodes multidomain, membrane-anchored proteins characterized by metalloprotease and disintegrin domains[1][2]. In mice, ADAM3 (cyritestin) is a functional sperm membrane protein implicated in mediating sperm-egg binding and fusion during fertilization, primarily through its disintegrin domain, which binds integrin-type receptors on the egg plasma membrane[1][3]. Disruption of the corresponding gene in male mice results in defective sperm-egg membrane adhesion and male infertility[1][3]. However, ADAM3B is not a functional protein in humans: it is considered a pseudogene in humans (non-functional gene locus)[5]; thus, it is not a therapeutically relevant target in human disease, nor is it an established drug target or biomarker. Most evidence for a direct function comes from mouse knockout models and in vitro assays[1][3]. As such, while it is part of the broader ADAM family, which has recognized members with clinical significance (e.g., ADAM10, ADAM17), ADAM3B itself should not be considered a therapeutic target for human diseases[5].

Other names
Cyritestin 2CYRN2ADAM metallopeptidase domain 3B (cyritestin 2)ADAM metallopeptidase domain 3B (non-functional)a disintegrin and metalloproteinase domain 3b (cyritestin 2)
02

Biological functions

Sperm-egg interaction (in mouse)Cell-cell adhesion (ADAM family)Gamete fusion (in mouse)
03

Disease associations

Infertility (in mouse)Other (no established human disease link)

Beyond the preview

Go deeper on ADAM metallopeptidase domain 3B (ADAM3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADAM metallopeptidase domain 3B (ADAM3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call